Literature DB >> 32821936

Traditional Chinese medicine use may reduce medical utility in patients with asthma: a nationwide population-based retrospective cohort study.

P F Liao1,2, Y T Wang3,4, Y H Wang5, J Y Chiou6, J C C Wei7,8,9,10.   

Abstract

BACKGROUND: Many patients with atopic diseases, including asthma, have sought complementary and alternative medicine and traditional Chinese medicine (TCM) treatments. But, limited clinical studies have yet examined TCM effects on medical utility in asthma patients. AIM: To assess the medical utility of TCM in patients with asthma.
DESIGN: Population-based retrospective cohort study.
METHODS: We performed a 13-year population-based retrospective cohort study. A total of 5235 asthma patients who were TCM users and 5235 propensity-score matched asthma patients who never used TCM were sampled from the Taiwan National Health Insurance Research Database from 2000 to 2012. We compared these two groups of patients to calculate their medical utility, including numbers of emergency visits and hospitalizations until 2013. Univariate analyses were performed using Chi-square tests for dichotomous variables and t-tests for continuous variables. Cox proportional hazard models were conducted to investigate the medical utility of asthma after TCM use.
RESULTS: Compared with non-TCM patients, TCM patients had a significantly decreased medical utility of asthma admission [adjusted odds ratio (OR) = 0.63; 95% confidence interval (CI): 0.46-0.85; P < 0.05], especially in patients who used TCM for >60 days. Asthma medical utility in asthma emergencies was significantly higher for male than for female patients (adjusted OR = 1.45; 95% CI: 1.08-1.96). The most frequently used TCMs for asthma control or cough treatment were antitussive agents.
CONCLUSION: This population-based retrospective cohort study showed a significantly decreased medical utility of emergency visits and admissions in TCM patients, especially using TCM for >60 days.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 32821936     DOI: 10.1093/qjmed/hcaa252

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  2 in total

1.  Molecular Mechanism Underlying Effects of Wumeiwan on Steroid-Dependent Asthma: A Network Pharmacology, Molecular Docking, and Experimental Verification Study.

Authors:  Mingsheng Lyu; Yahui Wang; Qiuyi Chen; Jingbo Qin; Dan Hou; Shuaiyang Huang; Dongmei Shao; Xuefeng Gong; Guirui Huang; Shiyu Zhang; Zhijie Zhang; Hongsheng Cui
Journal:  Drug Des Devel Ther       Date:  2022-03-30       Impact factor: 4.162

2.  Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study.

Authors:  Wei-Chiao Chang; Hanoch Livneh; Wei-Jen Chen; Chang-Cheng Hsieh; Yu-Han Wang; Ming-Chi Lu; How-Ran Guo; Tzung-Yi Tsai
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.